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In recent studies, we introduced the concept of functionalized magnetic force as a method to prevent nanoparticles from sticking to 
vessel walls caused by extensive simulation and in vitro experiments involving a Y-shaped channel. In this study, we further 
investigated the effectiveness of the functionalized magnetic force with a realistic 3D vessel through simulations. For the simulations, 
we considered a more realistic continuous injection of particles with different magnetic forces and frequencies. Based on the results 
from our simulation studies, we performed in vivo mice experiments to evaluate the effectiveness of using a functionalized magnetic 
force to aid magnetic nanoparticles (MNPs) in crossing the blood-brain barrier (BBB). To implement the functionalized magnetic 
force, we developed an electromagnetic actuator regulated by a programmable direct current (DC) power supply. Our results indicate 
that a functionalized magnetic field can effectively prevent MNPs from sticking, and also guide them across the BBB.  We used 770-nm 
fluorescent carboxyl MNPs in this study. Following intravenous administration of MNPs into mice, we applied an external magnetic 
field (EMF) to mediate transport of the MNPs across the BBB and into the brain. Furthermore, we evaluated the differential effects of 
functionalized magnetic fields (0.25, 0.5, and 1 Hz) and constant magnetic fields on the transport of MNPs across the BBB. Our results 
showed that a functionalized magnetic field is more effective than a constant magnetic field in the transport and uptake of MNPs 
across the BBB in mice. Specifically, applying a functionalized magnetic field with a 3 A current and 0.5 Hz frequency mediated the 
greatest transport and uptake of MNPs across the BBB in mice. 
 




AGNETIC NANOPARTICLES (MNPs) are a class of 
nanoparticles that can be manipulated under the 
influence of an external magnetic field (EMF). For drug 
delivery to brain cells, MNPs have been used as a vehicle to 
cross the blood-brain barrier (BBB) [1-2]. They can be guided 
by non-invasive magnetic forces through the vasculature and 
concentrated at a localized site within the brain. However, 
using a constant magnetic force may cause the particles to 
aggregate or stick to vessel walls, which can lead to 
blockages. To address this concern, we previously published 
the use of a functionalized magnetic field, or a field function 
(FF), to replace the constant magnetic force [3-4]. By 
intentionally changing the direction of the magnetic field, 
sticking and aggregation no longer occur. 
In this study, the effectiveness of the FF scheme was further 
evaluated using a realistic vessel. We chose a vessel from the 
human brain and created the vessel’s exact geometry using 
magnetic resonance imaging (MRI) images and a special 
procedure [5]. Also, instead of considering by injecting MNPs 
only one time, this study used a more realistic initial condition 
by injecting MNPs continuously for 30 s. In addition, 
simulations were performed with different magnitudes and 
frequencies of FF. Based on the simulation results, we 
performed in vivo mice experiments to evaluate the 
effectiveness of the FF in mediating MNP transport across the 
BBB. Collectively, our results indicated that the FF is an 
effective method for guiding MNPs across the BBB in mice, 
with the most optimal FF at a frequency of 0.5 Hz. 
II. FUNCTIONALIZED MAGNETIC FIELD TO AVOID STICKING 
AND AGGREGATION 
Since a magnetic force is proportional to the cube of the 
particle’s diameter, the force needed to navigate MNPs is not 
strong enough to overcome the drag force. Consequently, 
guidance of nanoparticles is not very effective. To effectively 
steer MNPs within blood vessels using existing 
magnetic/electromagnetic actuators, the direction of the 
magnetic force has to be perpendicular to blood flow [6]. The 
drag force exerted on a particle perpendicular to blood flow is 
less than that in the direction of the flow. Thus, a smaller 
magnetic force is required to steer the MNPs [6].  
However, with a constant perpendicular magnetic force, 
particles easily aggregate and stick to vessel walls. To address 
this concern, the concept of an FF was introduced [3]. In brief, 
the concept involves release of MNPs from the vessel wall by 
reversing the magnetic direction periodically. The FF is a 
unitless multiplier function that varies with time, which 
determines how to change the magnetic field gradient over 
time under the following constraints: 
 
M
0018-9464 (c) 2015 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TMAG.2015.2513601, IEEE
Transactions on Magnetics
> FOR CONFERENCE-RELATED PAPERS, REPLACE THIS LINE WITH YOUR SESSION NUMBER, E.G., AB-02 (DOUBLE-CLICK HERE) < 
 
2
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Figure 1 illustrates the concept of FF. In this figure, Tplus 
and Tminus are the times during which the FF (as well as the 
magnetic force) is positive and negative, respectively. T is the 
time period of the FF, and the duty ratio (D) and frequency (f) 
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Fig. 1. Field function characteristic. 
III. NUMERICAL SIMULATION STUDIES 
A. Simulation Model, Parameters, and Conditions 
 
 
Fig. 2. 3D vessel model for simulation studies.  
 
In this study, we first selected a vessel located in the human 
brain. Next, we extracted its geometry using MRI images via a 
special procedure [5]. Based on the extracted information, we 
created a three-dimensional (3-D) model of the vessel using 
computer-aided design (CAD) software. Finally, we imported 
this model into COMSOL software (COMSOL Inc., Palo Alto, 
CA, USA) prior to the simulation studies. The final 3-D model 
of the channel, with some of the geometric characteristics that 
were used for modeling, is shown in Fig. 2. We chose the 
outlet with the longest route and the most bifurcations (3).  
Simulation conditions are summarized in Table I. Blood 
flow was at a steady, creeping flow, which flowed into the 
channel from the inlet and exited the channel from the outlets. 
We selected fluid modeling parameters based on their 
similarity to blood behavior [6]. Blood flow inside the 
channels was simulated as a steady-state laminar flow and its 
velocity profile was calculated using the computational fluid 
dynamics (CFD) module of COMSOL. Unlike  studies [3], [6] 
that had considered by injecting MNPs only one time, in this 
study, we considered a more realistic initial condition by 
injecting 100 particles into the inlet in each step of 0.1sec  
during 30 sec. By implementing this continuous injecting 
condition, our simulations become more realistic and 
consequently, the difference between simulations and 
experiments has been shortened. 
Based on extensive simulation studies [3,6-7], the duty 
ratios that yielded optimal performances were in the range of 
0.6‒0.8. In this study, for simplicity, the duty ratio was fixed 
at 0.7. 
 
TABLE I. MODELLING PARAMETERS 
Parameter Value Unit 
Blood density 1050 kg/m3 
Blood viscosity 0.004 Pa.s 
Air relative permeability 1 - 
Blood relative permeability 1 - 
Blood temperature 293.15 K 
Particle diameter 770 nm 
particle density 6450 kg/m3 
Blood velocity 1  mm/s 
Vessel length 10 mm 
Vessel diameter 1 mm 
Input current to the actuator 1 to 6 A 
Saturation magnetization 106 kA/m 
 
B. Particles Guidance Performance 
 
TABLE II. PERCENTAGE OF PARTICLES AT THE CORRECT OUTLET IN 
SIMULATIONS 
Current 1A 2A 3A 4A 5A 6A 
0 Hz 0% 0% 0% 0% 0% 0% 
0.25 Hz 2.66% 2.13% 1.96% 1.93% 1.86% 1.86% 
0.5 Hz 6.51% 6.15% 10.0% 6.01% 5.98% 5.71% 
1 Hz 0% 0% 2.15% 2.82% 1.13% 2.43% 
 
Table II details the percentages of particles at the correct 
outlet during simulations using FF schemes with varying 
frequencies. The data in Table II clearly indicates that in cases 
in which the magnetic field is kept constant (0 Hz), particles 
are unable to reach the correct outlet regardless of the input 
current. This result occurs because all of the particles are stuck 
to vessel walls before they can reach the correct outlet. For the 
various FF schemes, we observed that the MNPs reach the 
correct outlet depending on the frequency and input current 
values. We observed optimal results at 0.5 Hz. This 
phenomenon can be explained as follows: as frequency 
increases, less particles are stuck at the vessel walls since the 
positive time Tplus is decreased. In this context, the negative 
time Tminus is long enough to release the particles from the 
walls. However, when the frequency is too high (> 0.5 Hz), 
the negative time Tminus is too small and the particles do not 
have enough time to release from the walls. 
The results from these simulations suggest that the FF can 
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effectively enhance MNPs guidance by preventing sticking 
and aggregation at vessel walls. Furthermore, we observed 
optimal results when the frequency of the FF was 0.5 Hz. 
IV. IN VIVO MICE EXPERIMENTS 
A. Electromagnetic actuator for implementing FF 
To implement the FF scheme, we used an electromagnetic 
magnetic actuator (EMA) that we designed in a previously 
study [4]. Figure 3 illustrates the experimental setup of the 
electromagnetic actuator system and its geometry. Geometric 




Fig. 3. Experimental setup of the proposed electromagnetic actuator. 
 
 
Fig. 4. Response time of the coil-core system.  
 
The magnetic field at the region of interest (ROI) was 60 
mm in diameter at the center of the actuation system, and was 
designed specifically for experiments involving mice. The 
magnetic force was controlled by a direct current (DC) power 
supply and the current in the coil. A current of up to 17 A 
could be applied to the coil-core system, which had a 20 Ω 
resistance and 0.42 H inductance. The rated power of the DC 
power supply was 6 kW. Figure 4 shows the response time of 
the coil-core system with a DC power supply. The 1 A current 
input command to the DC power supply was set as a step 
function at 1.797 s. At 2.014 s, the magnetic field response at 
the center of ROI reached 28.2 mT, meaning that the response 
time of our system was approximately 0.217s. This response 
time of EMA is mainly affected by the inductance of the coil 
and the response time of the DC power supply. Although this 
response time was quite slow, it was quick enough in the 
application to guide the particles (see B. Methods and 
conditions). In Fig. 5, we show the magnetic field surface in 
the ROI of a coil with and without a core. As shown in the 
figure, the core strengthens the magnetic field and its gradient 
at the ROI by approximately 10-fold.  
 
 
Fig. 5. Magnetic field surface of the left coil in the ROI with and without a 
core. 
B. Conditions and Method 
Yellow, fluorescent carboxyl MNPs (1% w/v) were 
purchased from Spherotech. The nanoparticles were 700–900 
mm in diameter (mean diameter = 770 nm).  
Male wild-type C57BL/6N mice (25–30 g, 8 weeks old) 
were purchased from Samtako Bio (Osan, South Korea). The 
mice were acclimatized for 1 week in the university animal 
house under a 12 h/12 h light/dark cycle (23ºC, 60% 
humidity), and were provided food and water ad libitum. 
Mice were divided randomly into seven groups (n = 5 mice 
per group; see below). All groups were treated intravenously 
(I.V.) with 0.4 mL of fluorophore-labeled MNPs and then 
exposed to various EMF conditions (i‒e) consisting of either a 
constant magnetic field (CMF) or a functionalized magnetic 
field (FMF) for 1 min. MNP uptake in the brain was verified 
by confocal microscopy (Fig. 6). 
 
(1). I.V. injection of saline, no exposure to EMF (control 
group) 
(2). I.V. injection of MNPs, no exposure to EMF 
(3). I.V. injection of MNPs, exposure to CMF (1 A) 
(4). I.V. injection of MNPs, exposure to CMF (3 A) 
(5). I.V. injection of MNPs, exposure to FMF (3 A, 0.25 Hz) 
(6). I.V. injection of MNPs, exposure to FMF (3 A, 0.5 Hz) 
(7). I.V. injection of MNPs, exposure to FMF (3 A, 1.0 Hz) 
 
Mice from all groups were sacrificed following treatment. 
All efforts were made to minimize suffering and the number 
of mice used. Experimental procedures were approved by the 
animal Ethics Committee of the Division of Applied Life 
Sciences, Department of Biology at Gyeongsang National 
University in South Korea.   
Brain tissues from all of the above-mentioned groups were 
collected after treatment. Transcardial perfusion was 
performed using 1× phosphate-buffered saline (PBS) followed 
by 4% ice-cold paraformaldehyde. Brain tissues were post-
fixed overnight in 4% paraformaldehyde and subsequently 
transferred to 20% sucrose until they settled at the bottom of 
the tube. Brains were frozen in optimal tissue cutting 
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temperature compound (Tissue-Tek O.C.T. compound; Sakura 
Finetek USA, Inc., Torrance, CA, USA) and then sectioned 
into 14 µm sections in the coronal plane with a CM 3050S 
cryostat (Leica, Wetzlar, Germany). Sections were thaw-
mounted on Probe-On positively charged slides (Thermo 
Fisher Scientific Inc., Waltham, MA, USA) and stored at ‒
70°C. Brain tissue slides were dried overnight and washed 
twice with 0.01 M PBS for 15 min each. Tissue sections were 
stained with 4’,6-diamidino-2-phenylindole (DAPI) for 10 
min, rinsed with PBS, and glass coverslips were mounted on 
the tissue slides using fluorescent mounting medium. Images 
were captured with a confocal laser scanning microscope 
(FluoView FV 1000; Olympus, Tokyo, Japan), with argon ion 
laser. The power of laser was 20%. The fluorescent carboxyl 
MNPs excitation spectra were ranging from 400-500 nm and it 
showed highly efficient fluorescence in the FITC channel at 
488 nm. The magnification was 10x with dried type lens. 
 
Fig. 6 Histogram showing the results of confocal microscopy analyzed by 
using the computer based Image J program. Data were expressed as the mean 
± SEM of experiments performed in triplicate (n=3). Significant differences 
were evaluated using a one-way analysis of variance (ANOVA) followed by 
the student t-test. Differences were considered to be statistically significant. 
Symbol *** represents a significant difference compared to the control group 
and constant magnetic field (***p<0.0001). 
 
Confocal analysis demonstrated that application of an EMF 
can facilitate the movement of MNPs across the BBB, 
resulting in MNP accumulation in the brain (Fig. 6). In the 
absence of an EMF, we observed no significant accumulation 
of MNPs in the brain. Under constant magnetic field 
conditions, when the value of the current increased from 1 A 
to 3 A, the magnetic field and magnetic field gradient 
increased, and as a result a greater magnetic force was 
produced. However, a higher magnetic force with a constant 
magnetic field increased particle aggregation, which 
negatively affected the particles’ movement across the BBB 
[8]. This phenomenon also occurred in the normal control 
mice, as shown in Fig. 6. To address the issue of aggregation, 
and to increase the uptake and transport of particles into the 
brain, we proposed the concept of a functionalized magnetic 
field [3]. By applying a functionalized magnetic field, the rate 
of particle transport across the BBB increased significantly 
compared to transport under a constant magnetic field with the 
same current (p < 0.0001). The results from this in vivo 
experiment suggest that using a functionalized 
electromagnetic field will reduce particle aggregation [3] and 
subsequently increase particle movement across the BBB. 
V. DISCUSSION AND CONCLUSION 
In this study, we showed that an FF can be utilized to 
prevent particle sticking and aggregation through extensive 
simulations by considering more realistic injection conditions 
of MNPs in a complex 3-D real-like vessel. The in vivo mice 
experiments were performed using an electromagnetic 
actuator that implemented the FF scheme. The various 
simulations and mice experiments showed that FF can be used 
to effectively prevent particle sticking and aggregation, 
subsequently resulting in particles crossing the BBB and 
accumulating in the brain. 
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